Xeris Pharmaceuticals(GB:0A8E)
$16.73+0.12 (+0.69%)
GB:0A8E
Xeris Pharmaceuticals ownership
$16.73
At close:+0.12 (+0.69%)
Xeris Pharmaceuticals (0A8E) Ownership - Who Owns Xeris Pharmaceuticals?
0 Followers
Xeris Pharmaceuticals (0A8E) Ownership Overview
- 4.85% Insiders
- 12.17% Mutual Funds
- 18.25% Other Institutional Investors
- 13.97% ETFs
- 50.75% Public Companies and Individual Investors
The ownership structure of Xeris Pharmaceuticals (GB:0A8E) stock is a mix of institutional, retail, and individual investors. Approximately 44.40% of the company’s stock is owned by Institutional Investors, 4.85% is owned by Insiders, and 50.75% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Xeris Pharmaceuticals (GB:0A8E) stock is a mix of institutional, retail, and individual investors. Approximately 44.40% of the company’s stock is owned by Institutional Investors, 4.85% is owned by Insiders, and 50.75% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Dec 18, 2025 | John Johnson | $976,234 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Deerfield Management Company, Lp | $410,005 | |
| Dec 31, 2025 | Entrypoint Capital, Llc | $534,451 | |
| Dec 31, 2025 | Driehaus Capital Management Llc | $23,397,450 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 14,659,299 | Institution | 8.02% | 245,176,776 |
| Vanguard | 8,212,872 | Institution | 4.50% | 137,360,284 |
| Ishares | 8,124,706 | Institution | 4.45% | 135,885,708 |
| Vanguard Index Funds | 7,180,117 | Institution | 3.93% | 120,087,457 |
| John Patrick Shannon | 2,898,933 | Insider | 1.59% | 48,484,654 |
| Tiaa-cref Funds | 2,731,436 | Institution | 1.50% | 45,683,267 |
| Fidelity Salem Street Trust | 2,055,229 | Institution | 1.12% | 34,373,705 |
| Spdr | 2,017,832 | Institution | 1.10% | 33,748,240 |
| Fidelity Concord Street Trust | 1,769,397 | Institution | 0.97% | 29,593,165 |
| Kevin Mcculloch | 1,584,208 | Insider | 0.87% | 26,495,879 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 7,180,117 | Institution | 3.93% | 120,087,457 |
| Tiaa-cref Funds | 2,731,436 | Institution | 1.50% | 45,683,267 |
| Fidelity Salem Street Trust | 2,055,229 | Institution | 1.12% | 34,373,705 |
| Fidelity Concord Street Trust | 1,769,397 | Institution | 0.97% | 29,593,165 |
| Vanguard Scottsdale Funds | 1,183,316 | Institution | 0.65% | 19,790,960 |
| Federated Hermes Mdt Series | 1,067,305 | Institution | 0.58% | 17,850,676 |
| Schwab Capital Trust | 577,876 | Institution | 0.32% | 9,664,976 |
| Dfa Investment Dimensions Group Inc | 530,141 | Institution | 0.29% | 8,866,608 |
| Vanguard World Fund | 514,791 | Institution | 0.28% | 8,609,879 |
| Vanguard Explorer Fund | 490,039 | Institution | 0.27% | 8,195,902 |
FAQ
Who Owns Xeris Pharmaceuticals (GB:0A8E)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 44.40% of the company's stock is held by institutional investors, 4.85% is held by insiders, and 50.75% is held by public companies and individual investors.
What percentage of Xeris Pharmaceuticals (GB:0A8E) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 44.40% of Xeris Pharmaceuticals (GB:0A8E) stock is held by institutional investors: 12.17% by mutual funds, 13.97% by ETFs and 18.25% by other institutional investors.
What percentage of Xeris Pharmaceuticals (GB:0A8E) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 50.75% of Xeris Pharmaceuticals (GB:0A8E) stock is held by public companies and individual investors.
Who owns the most shares of Xeris Pharmaceuticals (GB:0A8E)?
BlackRock, Inc. owns the most shares of Xeris Pharmaceuticals (GB:0A8E).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

